Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
CBFV vs NTRS vs STT vs CZWI vs BK vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Banks - Regional
Asset Management
Banks - Diversified
CBFV vs NTRS vs STT vs CZWI vs BK vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||||
|---|---|---|---|---|---|---|
| Industry | Banks - Regional | Asset Management | Asset Management | Banks - Regional | Asset Management | Banks - Diversified |
| Market Cap | $190M | $32.31B | $48.45B | $207M | $100.01B | $896.00B |
| Revenue (TTM) | $69M | $14.30B | $22.63B | $90M | $40.44B | $280.33B |
| Net Income (TTM) | $5M | $1.74B | $2.94B | $14M | $5.55B | $57.05B |
| Gross Margin | 62.5% | 56.5% | 61.4% | 54.7% | 48.9% | 60.0% |
| Operating Margin | 7.7% | 16.3% | 16.5% | 7.0% | 17.5% | 25.9% |
| Forward P/E | 12.6x | 16.1x | 13.5x | 11.8x | 16.2x | 14.4x |
| Total Debt | $35M | $16.43B | $29.80B | $52M | $33.88B | $942.38B |
| Cash & Equiv. | $32M | $61.13B | $131.36B | $119M | $131.52B | $343.34B |
CBFV vs NTRS vs STT vs CZWI vs BK vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| CB Financial Servic… (CBFV) | 100 | 171.9 | +71.9% |
| Northern Trust Corp… (NTRS) | 100 | 219.7 | +119.7% |
| State Street Corpor… (STT) | 100 | 263.8 | +163.8% |
| Citizens Community … (CZWI) | 100 | 312.8 | +212.8% |
| The Bank of New Yor… (BK) | 100 | 360.9 | +260.9% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CBFV vs NTRS vs STT vs CZWI vs BK vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CBFV has the current edge in this matchup, primarily because of its strength in income & stability and defensive.
- Dividend streak 1 yrs, beta 0.41, yield 2.6%
- Beta 0.41, yield 2.6%, current ratio 0.02x
- NIM 3.3% vs STT's 0.8%
- Beta 0.41 vs STT's 1.20, lower leverage
NTRS doesn't hold a clear category lead here; it's more of a secondary option in this specific comparison.
STT ranks third and is worth considering specifically for growth exposure.
- Rev growth 3.0%, EPS growth 14.5%
- +75.1% vs JPM's +21.8%
CZWI is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.50, Low D/E 27.6%, current ratio 3015.31x
- Lower P/E (11.8x vs 16.2x)
BK is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- Efficiency ratio 0.3% vs CBFV's 0.5% (lower = leaner)
- Efficiency ratio 0.3% vs CBFV's 0.5%
JPM is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 465.8% 10Y total return vs BK's 280.2%
- PEG 0.81 vs CZWI's 2.32
- 3.3% NII/revenue growth vs CBFV's -13.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.3% NII/revenue growth vs CBFV's -13.3% | |
| Value | Lower P/E (11.8x vs 16.2x) | |
| Quality / Margins | Efficiency ratio 0.3% vs CBFV's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.41 vs STT's 1.20, lower leverage | |
| Dividends | 2.6% yield, 1-year raise streak, vs JPM's 1.9% | |
| Momentum (1Y) | +75.1% vs JPM's +21.8% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs CBFV's 0.5% |
CBFV vs NTRS vs STT vs CZWI vs BK vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CBFV vs NTRS vs STT vs CZWI vs BK vs JPM — Financial Metrics
Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 2 of 6 categories
CZWI leads 1 • BK leads 1 • CBFV leads 0 • NTRS leads 0 • STT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 4083.7x CBFV's $69M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to CBFV's 7.1%.
| Metric | ||||||
|---|---|---|---|---|---|---|
| RevenueTrailing 12 months | $69M | $14.3B | $22.6B | $90M | $40.4B | $280.3B |
| EBITDAEarnings before interest/tax | $7M | $3.2B | $4.3B | $9M | $8.9B | $81.4B |
| Net IncomeAfter-tax profit | $5M | $1.7B | $2.9B | $14M | $5.5B | $57.0B |
| Free Cash FlowCash after capex | $17M | $4.7B | $2.7B | $11M | $5.2B | $100.9B |
| Gross MarginGross profit ÷ Revenue | +62.5% | +56.5% | +61.4% | +54.7% | +48.9% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +7.7% | +16.3% | +16.5% | +7.0% | +17.5% | +25.9% |
| Net MarginNet income ÷ Revenue | +7.1% | +12.1% | +13.0% | +16.0% | +13.7% | +20.4% |
| FCF MarginFCF ÷ Revenue | +24.8% | +33.1% | +12.1% | +12.4% | +12.8% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +93.5% | +7.1% | +23.0% | +63.0% | +25.3% | +16.0% |
Valuation Metrics
CZWI leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 14.7x trailing earnings, CZWI trades at a 64% valuation discount to CBFV's 40.8x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs CZWI's 2.90x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Market CapShares × price | $190M | $32.3B | $48.4B | $207M | $100.0B | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $193M | -$12.4B | -$53.1B | $140M | $2.4B | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 40.78x | 19.95x | 17.83x | 14.70x | 19.15x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 12.62x | 16.08x | 13.49x | 11.79x | 16.16x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.02x | 2.16x | 2.90x | 1.36x | 0.90x |
| EV / EBITDAEnterprise value multiple | 27.19x | -3.85x | -12.39x | 15.69x | 0.27x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 2.77x | 2.26x | 2.14x | 2.29x | 2.47x | 3.20x |
| Price / BookPrice ÷ Book value/share | 1.26x | 2.54x | 1.74x | 1.11x | 2.23x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 11.09x | 5.92x | 11.29x | 19.90x | 19.32x | 8.88x |
Profitability & Efficiency
JPM leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $3 for CBFV. CBFV carries lower financial leverage with a 0.22x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), BK scores 8/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | ||||||
|---|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +3.2% | +13.4% | +10.8% | +7.8% | +12.5% | +15.9% |
| ROA (TTM)Return on assets | +0.3% | +1.0% | +0.8% | +0.8% | +1.2% | +1.3% |
| ROICReturn on invested capital | +2.1% | +6.0% | +4.7% | +2.0% | +6.4% | +4.5% |
| ROCEReturn on capital employed | +2.9% | +9.0% | +4.5% | +0.6% | +8.0% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 7 | 6 | 8 | 5 |
| Debt / EquityFinancial leverage | 0.22x | 1.27x | 1.07x | 0.28x | 0.76x | 2.60x |
| Net DebtTotal debt minus cash | $3M | -$44.7B | -$101.6B | -$67M | -$97.6B | $599.0B |
| Cash & Equiv.Liquid assets | $32M | $61.1B | $131.4B | $119M | $131.5B | $343.3B |
| Total DebtShort + long-term debt | $35M | $16.4B | $29.8B | $52M | $33.9B | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.21x | 0.38x | 0.43x | 0.16x | 0.34x | 0.74x |
Total Returns (Dividends Reinvested)
BK leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BK five years ago would be worth $30,304 today (with dividends reinvested), compared to $16,257 for NTRS. Over the past 12 months, STT leads with a +75.1% total return vs JPM's +21.8%. The 3-year compound annual growth rate (CAGR) favors BK at 50.0% vs CBFV's 26.8% — a key indicator of consistent wealth creation.
| Metric | ||||||
|---|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +9.8% | +26.3% | +31.2% | +24.3% | +22.2% | -0.5% |
| 1-Year ReturnPast 12 months | +34.6% | +62.8% | +75.1% | +52.1% | +60.6% | +21.8% |
| 3-Year ReturnCumulative with dividends | +103.8% | +149.4% | +141.7% | +153.7% | +237.6% | +138.2% |
| 5-Year ReturnCumulative with dividends | +93.7% | +62.6% | +113.8% | +69.0% | +203.0% | +118.2% |
| 10-Year ReturnCumulative with dividends | +114.0% | +183.6% | +222.0% | +149.0% | +280.2% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +26.8% | +35.6% | +34.2% | +36.4% | +50.0% | +33.6% |
Risk & Volatility
Evenly matched — CBFV and STT each lead in 1 of 2 comparable metrics.
Risk & Volatility
CBFV is the less volatile stock with a 0.41 beta — it tends to amplify market swings less than STT's 1.20 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. STT currently trades 99.6% from its 52-week high vs CZWI's 94.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.41x | 1.07x | 1.20x | 0.50x | 0.86x | 0.94x |
| 52-Week HighHighest price in past year | $37.92 | $175.11 | $168.28 | $22.62 | $143.94 | $337.25 |
| 52-Week LowLowest price in past year | $27.11 | $107.08 | $95.67 | $12.83 | $87.41 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +98.9% | +99.6% | +99.6% | +94.9% | +98.6% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 67.1 | 57.6 | 68.3 | 51.2 | 70.9 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 4K | 1.0M | 1.8M | 41K | 2.8M | 7.0M |
Analyst Outlook
Evenly matched — CBFV and STT and BK and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CBFV as "Hold", NTRS as "Hold", STT as "Buy", CZWI as "Buy", BK as "Buy", JPM as "Buy". Consensus price targets imply 5.9% upside for JPM (target: $340) vs -11.8% for NTRS (target: $154). For income investors, CBFV offers the higher dividend yield at 2.58% vs BK's 1.45%.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $153.75 | $161.50 | — | $139.86 | $339.75 |
| # AnalystsCovering analysts | 3 | 35 | 37 | 2 | 29 | 61 |
| Dividend YieldAnnual dividend ÷ price | +2.6% | +1.8% | +1.8% | +1.7% | +1.4% | +1.9% |
| Dividend StreakConsecutive years of raises | 1 | 1 | 15 | 6 | 15 | 15 |
| Dividend / ShareAnnual DPS | $0.97 | $3.14 | $3.09 | $0.37 | $2.05 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.6% | +3.9% | +2.7% | +3.0% | +4.5% | +3.9% |
JPM leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CZWI leads in 1 (Valuation Metrics). 2 tied.
CBFV vs NTRS vs STT vs CZWI vs BK vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CBFV or NTRS or STT or CZWI or BK or JPM a better buy right now?
For growth investors, JPMorgan Chase & Co.
(JPM) is the stronger pick with 3. 3% revenue growth year-over-year, versus -13. 3% for CB Financial Services, Inc. (CBFV). Citizens Community Bancorp, Inc. (CZWI) offers the better valuation at 14. 7x trailing P/E (11. 8x forward), making it the more compelling value choice. Analysts rate State Street Corporation (STT) a "Buy" — based on 37 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CBFV or NTRS or STT or CZWI or BK or JPM?
On trailing P/E, Citizens Community Bancorp, Inc.
(CZWI) is the cheapest at 14. 7x versus CB Financial Services, Inc. at 40. 8x. On forward P/E, Citizens Community Bancorp, Inc. is actually cheaper at 11. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Citizens Community Bancorp, Inc. 's 2. 32x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CBFV or NTRS or STT or CZWI or BK or JPM?
Over the past 5 years, The Bank of New York Mellon Corporation (BK) delivered a total return of +203.
0%, compared to +62. 6% for Northern Trust Corporation (NTRS). Over 10 years, the gap is even starker: JPM returned +465. 8% versus CBFV's +114. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CBFV or NTRS or STT or CZWI or BK or JPM?
By beta (market sensitivity over 5 years), CB Financial Services, Inc.
(CBFV) is the lower-risk stock at 0. 41β versus State Street Corporation's 1. 20β — meaning STT is approximately 190% more volatile than CBFV relative to the S&P 500. On balance sheet safety, CB Financial Services, Inc. (CBFV) carries a lower debt/equity ratio of 22% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — CBFV or NTRS or STT or CZWI or BK or JPM?
By revenue growth (latest reported year), JPMorgan Chase & Co.
(JPM) is pulling ahead at 3. 3% versus -13. 3% for CB Financial Services, Inc. (CBFV). On earnings-per-share growth, the picture is similar: The Bank of New York Mellon Corporation grew EPS 27. 8% year-over-year, compared to -61. 3% for CB Financial Services, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CBFV or NTRS or STT or CZWI or BK or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus 7. 1% for CB Financial Services, Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 7. 0% for CZWI. At the gross margin level — before operating expenses — CBFV leads at 62. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CBFV or NTRS or STT or CZWI or BK or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Citizens Community Bancorp, Inc. 's 2. 32x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Citizens Community Bancorp, Inc. (CZWI) trades at 11. 8x forward P/E versus 16. 2x for The Bank of New York Mellon Corporation — 4. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JPM: 5. 9% to $339. 75.
08Which pays a better dividend — CBFV or NTRS or STT or CZWI or BK or JPM?
All stocks in this comparison pay dividends.
CB Financial Services, Inc. (CBFV) offers the highest yield at 2. 6%, versus 1. 4% for The Bank of New York Mellon Corporation (BK).
09Is CBFV or NTRS or STT or CZWI or BK or JPM better for a retirement portfolio?
For long-horizon retirement investors, CB Financial Services, Inc.
(CBFV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 41), 2. 6% yield, +114. 0% 10Y return). Both have compounded well over 10 years (CBFV: +114. 0%, STT: +222. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CBFV and NTRS and STT and CZWI and BK and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CBFV is a small-cap quality compounder stock; NTRS is a mid-cap quality compounder stock; STT is a mid-cap deep-value stock; CZWI is a small-cap deep-value stock; BK is a mid-cap quality compounder stock; JPM is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.